Verrica Pharmaceuticals Total Assets (Quarterly) Insights

Verrica Pharmaceuticals Inc (VRCA)

0.9945 0.00 (0.00%) USD | NASDAQ | Nov 22, 16:00

1.00 +0.01 (+0.55%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
September 30, 2024	32.93M
June 30, 2024	52.01M
March 31, 2024	66.31M
December 31, 2023	81.60M
September 30, 2023	97.15M
June 30, 2023	62.20M
March 31, 2023	68.64M
December 31, 2022	44.72M
September 30, 2022	49.15M
June 30, 2022	63.44M
March 31, 2022	71.62M
December 31, 2021	80.12M
September 30, 2021	88.76M
June 30, 2021	99.03M

Date	Value
March 31, 2021	108.10M
December 31, 2020	74.15M
September 30, 2020	79.94M
June 30, 2020	87.24M
March 31, 2020	94.44M
December 31, 2019	68.42M
September 30, 2019	76.07M
June 30, 2019	81.25M
March 31, 2019	85.98M
December 31, 2018	91.91M
September 30, 2018	98.80M
June 30, 2018	104.72M
March 31, 2018	29.40M
December 31, 2017	9.083M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

32.93M

Minimum

Sep 2024

108.10M

Maximum

Mar 2021

73.50M

Average

72.89M

Median

Total Assets (Quarterly) Benchmarks

Biomarin Pharmaceutical Inc	6.851B
Elite Pharmaceuticals Inc	88.20M
Eagle Pharmaceuticals Inc	404.82M
TELA Bio Inc	53.02M
Terns Pharmaceuticals Inc	378.23M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	66.98M
Shareholders Equity (Quarterly)	-34.05M
Debt to Equity Ratio	-1.272
Current Ratio	1.341
Net Debt Paydown Yield	-13.10%